Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0381 USD | +1.33% | +8.86% | -30.98% |
Chart calendar Navidea Biopharmaceuticals, Inc.
Upcoming events on Navidea Biopharmaceuticals, Inc.
Past events on Navidea Biopharmaceuticals, Inc.
2023-11-16 01:00 pm | Annual General Meeting |
2023-11-13 | Q3 2023 Earnings Release |
2023-07-27 01:00 pm | Extraordinary Shareholders Meeting |
2023-06-07 04:00 pm | Q1 2023 Earnings Release |
2023-03-21 05:00 pm | Q4 2022 Earnings Call |
2023-03-21 04:01 pm | Q4 2022 Earnings Release |
2022-12-08 01:00 pm | Annual General Meeting |
2022-11-15 05:00 pm | Q3 2022 Earnings Call |
2022-11-14 08:00 am | Q3 2022 Earnings Release |
2022-11-10 09:00 am | Annual Meeting of the Society for Immunotherapy of Cancer - Abstract #1161 |
2022-11-09 | American College of Rheumatology Convergence Conference |
2022-09-08 04:00 pm | Interim 2022 Earnings Call |
2022-08-15 08:30 am | Interim 2022 Earnings Release |
2022-06-11 09:00 pm | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No-197 |
2022-05-12 05:00 pm | Q1 2022 Earnings Call |
2022-05-12 07:30 am | Q1 2022 Earnings Release |
2022-04-20 05:00 pm | NAV3-32 Phase 2B Study Results Call |
2022-04-14 05:00 pm | Business Update Call |
2022-03-23 05:00 pm | FY 2021 Earnings Call |
2022-03-23 07:30 am | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,17 | 0,66 0,77 -14.18% | 0,92 0,90 2.18% |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -11,0 -11,0 0.09% | -10,7 -12,1 11.2% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.17% | -10,7 -12,1 11.02% |
Net income Million USD | Released Forecast Spread | 0,00 | -10,9 -11,0 0.16% | -11,4 -12,1 5.51% |
EPS USD | Released Forecast Spread | -1,80 | -0,76 -0,74 -3.4% | -0,48 -0,48 0% |
Announcement Date | - | 11/03/20 | 24/03/21 |
Quarterly results
Fiscal Period | December | 2021 Q3 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - |
EBIT Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,42 -3,52 31.26% |
Net income Million USD | Released Forecast Spread | -2,44 -3,52 30.8% |
EPS USD | Released Forecast Spread | -0,08 -0,11 27.27% |
Announcement Date | 10/11/21 |
Past sector events for Navidea Biopharmaceuticals, Inc.
2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
- Stock Market
- Equities
- NAVB Stock
- Calendar Navidea Biopharmaceuticals, Inc.